Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Shaman Pharmaceuticals |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002408 |
To evaluate the efficacy, safety, and durability of response of SP-303 in decreasing stool weight in AIDS patients with diarrhea over 6 days of treatment.
Condition | Intervention | Phase |
---|---|---|
Diarrhea HIV Infections |
Drug: Crofelemer |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind, Safety Study |
Official Title: | A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Patients must have:
Required:
- On stable medical regimen.
Study ID Numbers: | 293A, 37,554-210 |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002408 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Diarrhea Acquired Immunodeficiency Syndrome |
Virus Diseases Signs and Symptoms Sexually Transmitted Diseases, Viral Diarrhea Signs and Symptoms, Digestive |
HIV Infections Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome Retroviridae Infections Immunologic Deficiency Syndromes |
RNA Virus Infections Sexually Transmitted Diseases, Viral Disease Slow Virus Diseases Diarrhea Signs and Symptoms, Digestive Immune System Diseases Acquired Immunodeficiency Syndrome Infection |
Immunologic Deficiency Syndromes Virus Diseases Signs and Symptoms Pathologic Processes HIV Infections Syndrome Sexually Transmitted Diseases Lentivirus Infections Retroviridae Infections |